癌症幸存者卒中风险:基于人群队列研究的Meta分析
该Meta分析纳入20项基于人群的队列研究、共10,479,530名参与者,比较癌症幸存者与无癌症对照的卒中风险。结果显示癌症幸存者卒中相对风险为1.66(95%CI 1.35-2.04;p<0.001),头颈癌、血液系统肿瘤、肺癌、胰腺癌和胃癌幸存者风险显著升高,缺血性卒中风险增加较出血性卒中更明显。
要点
- 癌症幸存者总体卒中风险较无癌症人群升高,RR 1.66(95%CI 1.35-2.04)。
- 头颈癌、血液肿瘤、肺癌、胰腺癌和胃癌幸存者卒中风险显著增加。
- 女性、诊断时年龄<45岁及癌症生存期较短者风险更突出。
核心结论
- 癌症幸存者较无癌症人群卒中风险显著升高,RR 1.66(95%CI 1.35-2.04;p<0.001)。
- 癌症在卒中病因学中起重要作用,但纳入研究存在显著异质性,结果需谨慎解读。
研究设计与样本
- 系统检索PubMed、Embase和Cochrane Library自建库至2020年2月8日的基于人群的队列研究。
- 共纳入20项基于人群的队列研究,涉及10,479,530名参与者。
- 采用随机效应模型合并效应估计值及95%CI,并进行亚组分析和Meta回归探索异质性来源。
主要发现
- 癌症幸存者卒中相对风险为1.66(95%CI 1.35-2.04;p<0.001)。
- 头颈癌、血液系统肿瘤、肺癌、胰腺癌和胃癌幸存者卒中风险显著升高(均p<0.05),其他癌种未见显著升高。
- 女性癌症幸存者RR 1.38(95%CI 1.18-1.61;p<0.001),诊断时年龄<45岁者RR 2.57(95%CI 1.27-5.19;p=0.009),癌症生存期≥1-2年者RR 1.69(95%CI 1.18-2.42;p=0.004)。
- 癌症幸存者缺血性卒中风险RR 1.53(95%CI 1.28-1.84;p<0.001),较出血性卒中更显著。
临床怎么用
- 对癌症幸存者,尤其头颈癌、血液肿瘤、肺癌、胰腺癌和胃癌患者,应关注卒中风险并考虑早期预防。
- 女性、年轻(<45岁)及癌症生存期较短(≥1-2年)的幸存者可能需更密切的卒中风险评估。
局限性
- 纳入研究间存在显著异质性,结果需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Accumulating evidence suggests that cancer survivors may have a relatively higher risk of stroke. The aim of this meta-analysis was to determine whether cancer survivors have a relatively higher risk of stroke than cancer-free populations on the basis of published data from population-based cohort studies. METHODS: PubMed, Embase, and Cochrane Library were searched from inception to February 8, 2020, for population-based cohort studies. Effect estimates with 95% confidence intervals (CIs) were pooled using the random-effects model. We conducted subgroup analyses and meta-regression to explore sources of heterogeneity and the stability of the results. RESULTS: Twenty population-based cohort studies involving 10,479,530 participants were identified. Overall, the relative risk (RR) for stroke in cancer survivors was 1.66 (95% CI 1.35-2.04; p < 0.001) compared with that in cancer-free controls; survivors of head and neck, hematologic, lung, pancreas, and stomach cancer (all p < 0.05) showed consistently significant results, whereas no significant increased risk was observed for patients with other cancer types. The effects were more prominent in cancer survivors with female sex (RR 1.38, 95% CI 1.18-1.61; p < 0.001), younger age at cancer diagnosis (<45 years) (RR 2.57, 95% CI 1.27-5.19; p = 0.009), and shorter cancer survival duration (≥1-2 years) (RR 1.69, 95% CI 1.18-2.42; p = 0.004). Moreover, cancer survivors had a significantly increased risk of ischemic stroke (RR 1.53, 95% CI 1.28-1.84; p < 0.001) compared with hemorrhagic stroke. CONCLUSIONS: Cancer plays a critical role in the etiologic of stroke. Due to the existence of substantial heterogeneity among the included studies, the results should be interpreted with caution. However, early prevention and effective intervention of stroke in cancer survivors require attention from health policy makers.
引用
- Zhang F, Wang K, Du P, et al. Risk of Stroke in Cancer Survivors: A Meta-analysis of Population-Based Cohort Studies. Neurology. 2020. PMID: 33277416. doi:10.1212/WNL.0000000000011264
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。